Abstract
In the US 20.6% of adults and 19.5% of high school students are current cigarette smokers. Smoking is responsible for 5 million deaths worldwide each year and is known to cause more and a greater variety of human disease than any other known toxin. It causes multiple cancers, significant cardiovascular, respiratory and reproductive disease, and has been linked to health problems in most organ systems of the body. The harmful effects of tobacco begin in young smokers, who experience respiratory symptoms, increased rates of infection, and evidence of cardiovascular effects soon after beginning to smoke, even at low levels of cigarette use. Declines in the rate of cigarette smoking have stalled in the developed world. In the US, the Healthy People 2010 goal of decreasing current smoking in youth to below 16% has not been met. Smoking rates are increasing in the developing world, and there is already a rise in tobacco related problems in those areas least able to cope with the increased burden of disease. Continued efforts on a global scale are needed to combat the persistent and growing problem of tobacco use.
Keywords: Tobacco, smoking, health effects, epidemiology, adolescents
Current Pediatric Reviews
Title: The Epidemiology and Health Effects of Tobacco Use
Volume: 7 Issue: 2
Author(s): Joseph V. Schwab
Affiliation:
Keywords: Tobacco, smoking, health effects, epidemiology, adolescents
Abstract: In the US 20.6% of adults and 19.5% of high school students are current cigarette smokers. Smoking is responsible for 5 million deaths worldwide each year and is known to cause more and a greater variety of human disease than any other known toxin. It causes multiple cancers, significant cardiovascular, respiratory and reproductive disease, and has been linked to health problems in most organ systems of the body. The harmful effects of tobacco begin in young smokers, who experience respiratory symptoms, increased rates of infection, and evidence of cardiovascular effects soon after beginning to smoke, even at low levels of cigarette use. Declines in the rate of cigarette smoking have stalled in the developed world. In the US, the Healthy People 2010 goal of decreasing current smoking in youth to below 16% has not been met. Smoking rates are increasing in the developing world, and there is already a rise in tobacco related problems in those areas least able to cope with the increased burden of disease. Continued efforts on a global scale are needed to combat the persistent and growing problem of tobacco use.
Export Options
About this article
Cite this article as:
V. Schwab Joseph, The Epidemiology and Health Effects of Tobacco Use, Current Pediatric Reviews 2011; 7 (2) . https://dx.doi.org/10.2174/157339611795735585
DOI https://dx.doi.org/10.2174/157339611795735585 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Antioxidant and Antiinflammatory Activities of Curcumin on Diabetes Mellitus and its Complications
Current Pharmaceutical Design Is Mental Practice an Effective Adjunct Therapeutic Strategy for Upper Limb Motor Restoration After Stroke? A Systematic Review and Meta- Analysis
CNS & Neurological Disorders - Drug Targets Atrial Fibrillation Recurrence: The Roles of Hypertension, Duration of Atrial Fibrillation Disease, and Prolonged Signal-Averaged P Wave Duration
Current Cardiology Reviews Adherence to Cardiac Practice Guidelines in the Management of Non-ST-Elevation Acute Coronary Syndromes: A Systematic Literature Review
Current Cardiology Reviews Neural Control of Blood Pressure: Focusing on Capsaicin-Sensitive Sensory Nerves
Cardiovascular & Hematological Disorders-Drug Targets Having a Promising Efficacy on Type II Diabetes, It’s Definitely a Green Tea Time
Current Medicinal Chemistry Atenolol: Differences in Mode of Action Compared with other Antihypertensives.An Opportunity to Identify Features that Influence Outcome?
Current Pharmaceutical Design Role of microRNAs in Vascular Remodeling
Current Molecular Medicine Role of Heme Oxygenases in Cardiovascular Syndromes and Co-morbidities
Current Pharmaceutical Design The Metabolic Syndrome and Vascular Disease in Asia
Cardiovascular & Hematological Disorders-Drug Targets Functional Genomics of the Oxidative Stress Pathway
Current Hypertension Reviews Assessing Cardiovascular Risk in Patients with Diabetes: An Update
Current Cardiology Reviews Sympathetic Nervous System in Patients with Sleep Related Breathing Disorders
Current Hypertension Reviews Anti-apoptotic Serpins as Therapeutics in Cardiovascular Diseases
Cardiovascular & Hematological Disorders-Drug Targets Behcets Syndrome: Literature Review
Current Rheumatology Reviews Alteration of the Beta-Adrenergic Signaling Pathway in Human Heart Failure
Current Pharmaceutical Biotechnology Potentiating the Naturally Occurring Process for Repair of Damaged Heart
Current Pharmaceutical Design The Patented Uses of D-Ribose in Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Thromboxane Synthase Inhibitors and Thromboxane A2 Receptor Antagonists: A Quantitative Structure Activity Relationships (QSARs) Analysis
Current Medicinal Chemistry Epidemiology of Gout: Perspectives from the Past
Current Rheumatology Reviews